Chrome Extension

WeChat Mini Program

Use on ChatGLM

Log in

Academic Profile User Profile

My Following Paper Collections Browse History

COLUMBUS 7-Year Update: a Randomized, Open-Label, Phase III Trial of Encorafenib Plus Binimetinib Versus Vemurafenib or Encorafenib in Patients with BRAF V600E/K-mutant Melanoma

Dirk Schadendorf,Reinhard Dummer,Keith T. Flaherty,Caroline Robert,Ana Arance,Jan Willem B. de Groot,Claus Garbe,Helen J. Gogas,Ralf Gutzmer,Ivana Krajsova,Gabriella Liszkay,Carmen Loquai,Mario Mandala,Naoya Yamazaki,Paola Queirolo,Carolin Guenzel,Anna Polli, Mahgull Thakur,Alessandra di Pietro,Paolo A. Ascierto

European Journal of Cancer（2024）

Cited 7|Views32

Key words

BRAF-mutant,Melanoma,Encorafenib,Binimetinib

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined